Intrinsiqs

Is Bruker Corporation overvalued?

Bruker Corporation (BRKR) looks fairly valued — trading about 5% below its fair value.

Fairly valued
Current price $64.18 Fair value $67.67
Price
$64.18
Fair value
$67.67
Current P/E
35.3
Normal P/E
37.2
Market cap
$9.77B
Dividend yield
0.3%
Return on equity
-2.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BRKR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated